| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,362 |
5,534 |
$233K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,059 |
1,843 |
$114K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,104 |
2,736 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,542 |
778 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,774 |
1,608 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
395 |
350 |
$12K |
| 96160 |
|
516 |
273 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
70 |
53 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
65 |
51 |
$4K |
| 99173 |
|
341 |
288 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
47 |
41 |
$3K |
| 92551 |
|
339 |
286 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
57 |
52 |
$3K |
| 96127 |
|
371 |
220 |
$2K |
| 3008F |
|
5,046 |
4,356 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
29 |
26 |
$1K |
| 87807 |
|
90 |
83 |
$911.63 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
15 |
$389.40 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
25 |
$347.81 |
| 85018 |
|
38 |
28 |
$103.95 |
| 36415 |
Collection of venous blood by venipuncture |
35 |
25 |
$81.97 |
| 36416 |
|
36 |
27 |
$64.92 |